The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome

CONCLUSIONS: Administration of inhalational dornase alfa via a filtered nebulizer medication system or through an adapter in a ventilator circuit should be considered in all COVID-19-positive patients with ARDS as early in the disease course as possible.PMID:33986957 | PMC:PMC8074548 | DOI:10.1155/2021/8881115

Source: Critical Care Research and Practice - May 14, 2021 Category: Intensive Care Authors: Andrew Toma Christina Darwish Michele Taylor Justin Harlacher Ribal Darwish Source Type: research